Bellinger Andrew
- SEC CIK
- 0001864116
No open-market purchases or sales filed in the past year.
Current role at each company
- VERV Verve Therapeutics, Inc.Chief Scientific Officeras of Feb 16, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bellinger Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Bellinger AndrewCSO & CMO | SSale | −865 | $22.95 | −$19.9K | −11.5%6.63K after | |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Bellinger AndrewCSO & CMO | SSale | −10.0K | $39.90 | −$399.0K | −60.1%6.63K after | |
| Sep 27, 2022 (view filing) | Sep 23 | 4 days | Bellinger AndrewCSO & CMO | SSale | −60.0K | $35.34 | −$2.12M | −90.1%6.63K after | 4 lots |
| Jul 22, 2022 (view filing) | Jul 20 | 2 days | Bellinger AndrewCSO & CMO | SSale | −20.0K | $34.90 | −$698.0K | −75.1%6.63K after | |
| Jul 15, 2022 (view filing) | Jul 13 | 2 days | Bellinger AndrewCSO & CMO | SSale | −10.0K | $24.90 | −$249.0K | −60.1%6.63K after | |
| Dec 27, 2021 (view filing) | Dec 22 | 5 days | Bellinger AndrewChief Scientific Officer | SSale | −15.0K | $38.70 | −$580.4K | −75.0%5.00K after | 3 lots |